Globus Medical, Inc.
GMED NYSEHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 6, 2026
ET
EPS Est.
1.10
EPS Actual
1.34
Revenue Est.
$782.9M
Revenue Actual
$789.6M
Next Earnings Report
Date
Nov 5, 2026 · Thu
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
1.19
Revenue Est.
$791.5M
Company Overview
Globus Medical, Inc. (ticker GMED) is listed on NYSE with a market cap of about $11.72B. Its next earnings report (FY2026 Q3) is expected on Nov 5, 2026 (ET), After-market, with consensus EPS of 1.19. In the last 15 reported quarters, EPS beat consensus estimates 14 times.
Actual EPS TrendRecently15Term · Feb 21, 2023 → Aug 6, 2026
Feb 21, 2023Range: 0.53 ~ 1.34Aug 6, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 6, 2026 | -- | 1.10 | Above forecast↑1.34 | $782.9M | $789.6M |
| May 7, 2026 | -- | 0.92 | Above forecast↑1.12 | $740.3M | $759.9M |
| Feb 24, 2026 | -- | 1.06 | Above forecast↑1.28 | $801.7M | $826.4M |
| Nov 6, 2025 | -- | 0.78 | Above forecast↑1.18 | $734.7M | $769M |
| Aug 7, 2025 | -- | 0.76 | 0.86 | $742.7M | $745.3M |
| May 8, 2025 | -- | 0.74 | 0.68 | $625.9M | $598.1M |
| Feb 20, 2025 | -- | 0.74 | 0.84 | $645.7M | $657.3M |
| Nov 5, 2024 | -- | 0.65 | Above forecast↑0.83 | $604.7M | $625.7M |
| Aug 6, 2024 | -- | 0.68 | 0.75 | $615.3M | $629.7M |
| May 7, 2024 | -- | 0.57 | Above forecast↑0.72 | $586.8M | $606.7M |
| Feb 20, 2024 | -- | 0.59 | 0.60 | $607.1M | $616.5M |
| Nov 7, 2023 | -- | 0.54 | 0.57 | $268.8M | $383.6M |
| Aug 3, 2023 | -- | 0.59 | 0.63 | $279.7M | $291.6M |
| May 4, 2023 | -- | 0.51 | 0.53 | $254.9M | $276.7M |
| Feb 21, 2023 | -- | 0.56 | 0.59 | $276.7M | $274.5M |
Original Filings (SEC)
10-Q2026-08-06 ↗
8-K2026-08-06 ↗
8-K2026-06-04 ↗
10-Q2026-05-07 ↗
8-K2026-05-07 ↗
8-K2026-03-23 ↗
10-K2026-02-24 ↗
8-K2026-02-24 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
